A YAP/FOXM1 axis mediates EMT-associated EGFR inhibitor resistance and increased expression of spindle assembly checkpoint components | Science Translational Medicine
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer | Clinical and Translational Oncology
Kidney function trajectory in BBS subjects. (A) eGFR declines with age... | Download Scientific Diagram
IJMS | Free Full-Text | The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the EGFR-Mutated Lung Cancer
Cancers | Free Full-Text | Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients | British Journal of Cancer
Inhibiting Epidermal Growth Factor Receptor Improves Structural, Locomotor, Sensory, and Bladder Recovery from Experimental Spinal Cord Injury | Journal of Neuroscience
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
Materials | Free Full-Text | Anti-EGFR-Coated Gold Nanoparticles In Vitro Carry 5-Fluorouracil to Colorectal Cancer Cells
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
The epidermal growth factor receptor variant III (EGFRvIII): where wild things are altered - Gan - 2013 - The FEBS Journal - Wiley Online Library
EGFR blockade promotes morphological and functional rec | Open-i
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
Inhibition of Brain Epidermal Growth Factor Receptor Activation: A Novel Target in Neurodegenerative Diseases and Brain Injuries | Molecular Pharmacology
Piezo1 activates noncanonical EGFR endocytosis and signaling | Science Advances
EGFR targeting for cancer therapy: Pharmacology and immunoconjugates with drugs and nanoparticles - ScienceDirect
Promotion or remission: a role of noncoding RNAs in colorectal cancer resistance to anti-EGFR therapy | Cell Communication and Signaling | Full Text
Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer | Experimental & Molecular Medicine
Full article: Synthesis, characterization and preliminary biological evaluation of chrysin amino acid derivatives that induce apoptosis and EGFR downregulation
eGFR alto, basso e valori normali
Cancers | Free Full-Text | Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
mTOR-Rictor-EGFR axis in oncogenesis and diagnosis of glioblastoma multiforme | SpringerLink
Uncommon EGFR mutations in non-small-cell lung cancer: A systematic literature review of prevalence and clinical outcomes - ScienceDirect
Epidermal growth factor receptor mutations in lung cancer | Nature Reviews Cancer
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality
ERBB receptors and cancer: the complexity of targeted inhibitors | Nature Reviews Cancer
The EGFR-mTOR pathway. Schematic figure displaying the molecular... | Download Scientific Diagram
Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy | Journal of Medicinal Chemistry
